iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer, today announces that the innovative medicine designation, the Innovation Passport, has been awarded for roginolisib, for the.
/PRNewswire/ iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer, today announces the.
NeoPhore completes extension to Series B financing to further advance discovery pipeline prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.